Company profile for Allegria Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Allegria Therapeutics is a biotechnology company developing mast cell–targeted therapies for allergies and inflammatory diseases. Founded in 2023 in Basel, Switzerland, by Forty51 Ventures, the company focuses on selectively modulating mast cell activity to address conditions driven by mast cell dysfunction. Backed by seed funding and a 2025 extension, Allegria advances a differentiated pipeline aimed at improving patient qu...
Allegria Therapeutics is a biotechnology company developing mast cell–targeted therapies for allergies and inflammatory diseases. Founded in 2023 in Basel, Switzerland, by Forty51 Ventures, the company focuses on selectively modulating mast cell activity to address conditions driven by mast cell dysfunction. Backed by seed funding and a 2025 extension, Allegria advances a differentiated pipeline aimed at improving patient quality of life through innovative and sustainable therapeutic approaches.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Switzerland
Address
Address
Basel, Switzerland
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty